Selank Protects Rat Liver from Damage Caused by Chronic Stress
Background
Prolonged exposure to chronic stress is a significant public health concern, known to induce detrimental effects on various organ systems, including the liver. This stress can lead to severe morphological changes such as hydropic degeneration of hepatocytes (liver cells), altered nuclear-to-cytoplasmic ratios, and focal tissue necrosis, contributing to overall hepatic dysfunction and inflammation. Despite the well-documented impact of stress on liver health, effective pharmacological interventions to prevent these specific cellular and structural alterations remain limited. This study addresses whether the synthetic anxiolytic peptide Selank can mitigate the morphological damage inflicted upon the liver by chronic psychological stress.
Results
Chronic foot-shock stress in control rats induced significant hepatic damage, characterized by widespread hydropic degeneration of hepatocytes, a marked increase in the nucleus/cytoplasm ratio, and the appearance of focal necroses and lymphohistiocyte infiltration. Administration of Selank at all tested doses (100, 300, and 1000 µg/kg) consistently and significantly reduced the intensity of these stress-induced degenerative changes in the liver morphology. Specifically, Selank at doses of 300 µg/kg and 1000 µg/kg was particularly effective in restoring the altered nucleus/cytoplasm ratio in hepatocytes, indicating a reversal of stress-induced cellular swelling and nuclear changes. The study concluded that the maximum stress-limiting and protective effect on liver morphology was achieved with the 300 µg/kg dose of Selank, suggesting an optimal therapeutic concentration for mitigating hepatic damage. This demonstrates a clear dose-dependent protective action, where higher doses did not necessarily confer additional benefits.
Why It Matters
This study provides compelling evidence for Selank's potential as a potent hepatoprotective agent, offering a novel therapeutic strategy against liver damage caused by chronic psychological stress. Given the increasing prevalence of stress-related disorders and their systemic impact on organ health, identifying compounds that can mitigate such damage is critically important. This research suggests Selank could be a promising candidate for preventing stress-related liver pathologies in humans, particularly in individuals exposed to prolonged psychological or physiological stressors. Future research should focus on elucidating the precise molecular mechanisms underlying Selank's protective effects and validating these findings in larger, more complex animal models before progressing to human clinical trials to confirm its safety and efficacy.